Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) EBT (2020 - 2025)

Historic EBT for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to -$7.2 million.

  • Bolt Biotherapeutics' EBT rose 5238.53% to -$7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.8 million, marking a year-over-year increase of 3859.66%. This contributed to the annual value of -$67.8 million for FY2024, which is 202.9% up from last year.
  • Latest data reveals that Bolt Biotherapeutics reported EBT of -$7.2 million as of Q3 2025, which was up 5238.53% from -$8.6 million recorded in Q2 2025.
  • Bolt Biotherapeutics' 5-year EBT high stood at -$7.2 million for Q3 2025, and its period low was -$27.2 million during Q4 2021.
  • Moreover, its 5-year median value for EBT was -$18.0 million (2023), whereas its average is -$18.1 million.
  • Per our database at Business Quant, Bolt Biotherapeutics' EBT plummeted by 11326.52% in 2021 and then surged by 5937.25% in 2025.
  • Quarter analysis of 5 years shows Bolt Biotherapeutics' EBT stood at -$27.2 million in 2021, then increased by 26.37% to -$20.0 million in 2022, then rose by 10.47% to -$17.9 million in 2023, then rose by 10.99% to -$15.9 million in 2024, then skyrocketed by 54.66% to -$7.2 million in 2025.
  • Its EBT stands at -$7.2 million for Q3 2025, versus -$8.6 million for Q2 2025 and -$11.1 million for Q1 2025.